ABSCI CORP Effective Tax Rate
ABSCI CORP (ABSI) reported Effective Tax Rate of -0.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-24
- ABSCI CORP effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was 0.00%, a 100.00% decline year-over-year.
- ABSCI CORP effective income tax rate reconciliation, percent for the quarter ending 2022-09-30 was 1.10%, a 83.58% decline year-over-year.
- ABSCI CORP effective income tax rate reconciliation, percent for the quarter ending 2022-06-30 was 0.90%, a 92.50% decline year-over-year.
- ABSCI CORP effective income tax rate reconciliation, percent for the quarter ending 2022-03-31 was 2.20%.
- ABSCI CORP effective income tax rate reconciliation, percent for fiscal 2025 was -0.10%.
- ABSCI CORP effective income tax rate reconciliation, percent for fiscal 2024 was -0.10%.
- ABSCI CORP effective income tax rate reconciliation, percent for fiscal 2023 was -0.10%, a 125.00% decline from fiscal 2022.
- ABSCI CORP effective income tax rate reconciliation, percent for fiscal 2022 was 0.40%, a 95.06% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | -0.10% 10-K · filed 2026-03-24 | ||||
| 2024-12-31 | -0.10% 10-K · filed 2026-03-24 | ||||
| 2023-12-31 | -0.10% 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | 0.10% 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | 0.40% 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | 1.10% 10-Q · filed 2022-11-09 | 0.00% 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | 0.90% 10-Q · filed 2022-08-11 | 0.60% 10-Q · filed 2023-08-14 | -0.60% 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 2.20% 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | 8.10% 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 6.70% 10-Q · filed 2021-11-09 | 9.30% 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | 12.00% 10-Q · filed 2021-09-07 | 10.50% 10-Q · filed 2021-09-07 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |